Mammography Procedure Articles & Analysis
5 news found
Ultravist-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure CEM is emerging modality combining digital mammography with the administration of a contrast agent Strategically expands Bayer’s portfolio in breast imaging, including contrast agents and ...
ByBayer AG
CONFIDENCE registry endpoints to be analyzed include: Specificity, negative-likelihood ratio, sensitivity, and positive-likelihood ratio for the Imagio® System versus other standard-of-care imaging modalities, Use of the Imagio® System in comparison to, and in combination with, other imaging modalities in impacting the decision to biopsy, Quality of Life Assessment – Testing ...
QView Medical is the only FDA AI Ultrasound Technology approved for breast screening. But now, we are moving beyond the clinical suite. QView is joining women in the initiative around Breast Cancer with the launch of AmIDense.com and the supporting #AmIDense. Let's START the conversation around Breast Density. The 2021 American Cancer Society's estimate is 280,000 women will be diagnosed with ...
Rezolut, LLC and CureMetrix, Inc. have launched a pilot program in the Greater New York City area with the aim of pairing advanced technology with operational excellence to improve breast cancer detection in women receiving routine screening mammograms. Rezolut, LLC is a national, emerging platform of diagnostic medical imaging services, serving patients across the United States with 23 ...
All of these TULSA-PRO® systems will be placed under Profound’s per procedure business model. The initial geographic focus of the relationship will be in the State of Florida, with Texas and Pennsylvania expected to follow. ...